We found a positive association between TFAP2B and AP-1 expression in papillary thyroid carcinoma patients, but due to a few studies which assessed their expression, we assessed the expression of another biomarker which is JAZF1. The gene discussed is JAZF1; the disease is differentiated thyroid carcinoma.